Fluticasone furoate/vilanterol
id:
fluticasone-furoate-vilanterol-184-8365542
title:
Fluticasone furoate/vilanterol
text:
Fluticasone furoate/vilanterol, sold under the brand name Breo Ellipta among others, is a combination medication for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It contains fluticasone furoate, an inhaled corticosteroid, and vilanterol, an ultra-long-acting β2 agonist (ultra-LABA). In 2013, the drug was approved for use in the United States by the Food and Drug Administration (FDA) for long-term maintenance treatment of airflow obstruction in people with COPD, inclu
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug formulation
original url:
https://en.wikipedia.org/wiki/Fluticasone_furoate/vilanterol
date created:
2013-05-13T13:07:28Z
date modified:
2024-09-07T06:31:47Z
main entity:
{"identifier":"Q17127633","url":"https://www.wikidata.org/entity/Q17127633"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/93/Fluticasone_furoate_and_vilanterol.svg","width":512,"height":793}
fields total:
13
integrity:
16